Literature DB >> 8662674

Cytokines and insulin induce cationic amino acid transporter (CAT) expression in cardiac myocytes. Regulation of L-arginine transport and no production by CAT-1, CAT-2A, and CAT-2B.

W W Simmons1, E I Closs, J M Cunningham, T W Smith, R A Kelly.   

Abstract

Cytokine-dependent production of nitric oxide (NO) by rat cardiac myocytes is a consequence of increased expression of the inducible isoform of nitric oxide synthase (iNOS or NOS2) and, in the presence of insulin, depresses the contractile function of these cells in vivo and in vitro. Experiments reported here show that L-lysine, a competitive antagonist of L-arginine uptake, suppressed NO production (detected as nitrite accumulation) by interleukin (IL)-1beta and interferon (IFN) gamma-pretreated cardiac myocytes by 70%, demonstrating that NO production is dependent on L-arginine uptake. Cardiac myocytes constitutively exhibit a high-affinity L-arginine transport system (Km = 125 microM; Vmax = 44 pmol/2 X 10(5) cells/min). Following a 24-h exposure to IL-1beta and IFNgamma, arginine uptake increases Vmax = 167 pmol/2 X 10(5) cells/min) and a second low-affinity L-arginine transporter activity appears (Km = 1.2 mM). To examine the molecular basis for these cytokine-induced changes in arginine transport, we examined expression of three related arginine transporters previously identified in other cell types. mRNA for the high-affinity cationic amino acid transporter-1 (CAT-1) is expressed in resting myocytes and steady-state levels increase by 10-fold following exposure to IL-1beta and IFNgamma. Only cytokine-pretreated myocytes expressed a second high-affinity L-arginine transporter, CAT-2B, as well as a low-affinity L-arginine transporter, CAT-2A. In addition, insulin, which potentiated cytokine-dependent NO production independent of any change in NOS activity, increased myocyte L-arginine uptake by 2-fold and steady-state levels of CAT-1, but not CAT-2A or CAT-2B mRNA. Thus, NO production by cardiac myocytes exposed to IL-1beta plus IFNgamma appears to be dependent on the coinduction of CAT-1, CAT-2A, and CAT-2B, while insulin independently augments L-arginine transport through CAT- 1.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8662674     DOI: 10.1074/jbc.271.20.11694

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

1.  Nitric oxide can acutely modulate its biosynthesis through a negative feedback mechanism on L-arginine transport in cardiac myocytes.

Authors:  Jiaguo Zhou; David D Kim; R Daniel Peluffo
Journal:  Am J Physiol Cell Physiol       Date:  2010-05-26       Impact factor: 4.249

2.  Cardiac L-arginine transport: the CAT is back.

Authors:  Carmelle V Remillard; Jason X-J Yuan
Journal:  J Physiol       Date:  2007-03-15       Impact factor: 5.182

3.  L-arginine stimulates CAT-1-mediated arginine uptake and regulation of inducible nitric oxide synthase for the growth of chick intestinal epithelial cells.

Authors:  Chao Yuan; Xiaoyun Zhang; Qiang He; Junming Li; Jianjun Lu; Xiaoting Zou
Journal:  Mol Cell Biochem       Date:  2014-10-22       Impact factor: 3.396

4.  Transmembrane signalling mechanisms regulating expression of cationic amino acid transporters and inducible nitric oxide synthase in rat vascular smooth muscle cells.

Authors:  A R Baydoun; S M Wileman; C P Wheeler-Jones; M S Marber; G E Mann; J D Pearson; E I Closs
Journal:  Biochem J       Date:  1999-11-15       Impact factor: 3.857

5.  Exogenous IL-19 attenuates acute ischaemic injury and improves survival in male mice with myocardial infarction.

Authors:  Weishuai An; Yongsheng Yu; Yuefan Zhang; Zhigang Zhang; Yunhua Yu; Xianxian Zhao
Journal:  Br J Pharmacol       Date:  2019-01-08       Impact factor: 8.739

6.  Insulin requires A1 adenosine receptors expression to reverse gestational diabetes-increased L-arginine transport in human umbilical vein endothelium.

Authors:  Enrique Guzmán-Gutiérrez; Axel Armella; Fernando Toledo; Fabián Pardo; Andrea Leiva; Luis Sobrevia
Journal:  Purinergic Signal       Date:  2015-12-28       Impact factor: 3.765

7.  No effect of acute L-arginine supplementation on O₂ cost or exercise tolerance.

Authors:  Anni Vanhatalo; Stephen J Bailey; Fred J DiMenna; Jamie R Blackwell; Gareth A Wallis; Andrew M Jones
Journal:  Eur J Appl Physiol       Date:  2013-02-20       Impact factor: 3.078

Review 8.  Arginine metabolism: nitric oxide and beyond.

Authors:  G Wu; S M Morris
Journal:  Biochem J       Date:  1998-11-15       Impact factor: 3.857

9.  Characteristics and function of cardiac mitochondrial nitric oxide synthase.

Authors:  Elena N Dedkova; Lothar A Blatter
Journal:  J Physiol       Date:  2008-12-22       Impact factor: 5.182

10.  Activation of SphK1 by K6PC-5 Inhibits Oxygen-Glucose Deprivation/Reoxygenation-Induced Myocardial Cell Death.

Authors:  Jun-jie Shao; Yi Peng; Li-ming Wang; Jian-kai Wang; Xin Chen
Journal:  DNA Cell Biol       Date:  2015-08-26       Impact factor: 3.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.